NFKB1 and Alzheimer disease: External application of an oligodeoxynucleotide ointment that induces NF-κB activation could improve dermatitis symptoms in the NC/Nga atopic mouse model, indicating that NF-κB deficiency was related to AD pathogenesis [85].